Age: 18+
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Phase 2
Waitlist Available
Sponsor: Biohaven Therapeutics Ltd.
No Placebo Group
Prior Safety Data
Trial Summary
What is the purpose of this trial?The purpose of this study is to evaluate the long-term safety and tolerability of BHV-7000 in subjects with bipolar I disorder.
Eligibility Criteria
This trial is for individuals who have bipolar I disorder and have completed the parent study BHV7000-204. Women of childbearing potential (WOCBP) must not be pregnant, breastfeeding, or lactating to participate.Inclusion Criteria
Key
Treatment Details
The focus of this study is on assessing the long-term safety and tolerability of a medication called BHV-7000 in people with bipolar I disorder.
1Treatment groups
Experimental Treatment
Group I: BHV-7000Experimental Treatment1 Intervention
Find a clinic near you
Research locations nearbySelect from list below to view details:
Uptown Research InstituteChicago, IL
Arch Clinical TrialsSaint Louis, MO
Pillar Clinical Research, LLCRichardson, TX
NRC Research InstituteOrange, CA
More Trial Locations
Loading ...
Who is running the clinical trial?
Biohaven Therapeutics Ltd.Lead Sponsor